0001209191-22-053712.txt : 20221014
0001209191-22-053712.hdr.sgml : 20221014
20221014192550
ACCESSION NUMBER: 0001209191-22-053712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220826
FILED AS OF DATE: 20221014
DATE AS OF CHANGE: 20221014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sinclair Andrew
CENTRAL INDEX KEY: 0001762451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36593
FILM NUMBER: 221312368
MAIL ADDRESS:
STREET 1: C/O SOLENO THERAPEUTICS INC.
STREET 2: 1235 RADIO ROAD, SUITE 110
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLENO THERAPEUTICS INC
CENTRAL INDEX KEY: 0001484565
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 770523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 203 REDWOOD SHORES PARKWAY
STREET 2: SUITE 500
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-213-8444
MAIL ADDRESS:
STREET 1: 203 REDWOOD SHORES PARKWAY
STREET 2: SUITE 500
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Capnia, Inc.
DATE OF NAME CHANGE: 20100219
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-26
0
0001484565
SOLENO THERAPEUTICS INC
SLNO
0001762451
Sinclair Andrew
203 REDWOOD SHORES PKWY, STE 500
REDWOOD CITY
CA
94065
1
0
0
0
Stock option (right to buy)
23.55
2028-12-21
Common Stock
1333
1333
D
Stock option (right to buy)
39.45
2029-06-10
Common Stock
823
823
D
Stock option (right to buy)
51.15
2030-05-18
Common Stock
635
635
D
Stock option (right to buy)
33.60
2031-01-08
Common Stock
2666
2666
D
Stock option (right to buy)
15.30
2031-06-01
Common Stock
2124
2124
D
Stock option (right to buy)
2.55
2032-06-01
Common Stock
2666
2666
D
The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022.
One forty-eighth (1/48th) of the shares subject to the Option shall vest on the first month anniversary of December 21, 2018 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person continuing to be a Service Provider through each such date.
All of the shares subject to this option are fully vested and exercisable as of the date hereof.
The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of June 1, 2022 or the day before the next annual stockholder meeting, subject to Reporting Person continuing to be a Service Provider through each such date.
The Reporting Person is no longer deemed to share an indirect pecuniary interest in the securities held by Abingworth Bioventures VII, LP and therefore no longer reports those securities on his Section 16 reports.
/s/ Anish Bhatnagar, Attorney-in-Fact
2022-10-14